189 related articles for article (PubMed ID: 19384295)
21. Epigenetic Inactivation of α-Internexin Accelerates Microtubule Polymerization in Colorectal Cancer.
Li Y; Bai L; Yu H; Cai D; Wang X; Huang B; Peng S; Huang M; Cao G; Kaz AM; Grady WM; Wang J; Luo Y
Cancer Res; 2020 Dec; 80(23):5203-5215. PubMed ID: 33051252
[TBL] [Abstract][Full Text] [Related]
22. Aberrant hypermethylation of OGDHL gene promoter in sporadic colorectal cancer.
Khalaj-Kondori M; Hosseinnejad M; Hosseinzadeh A; Behroz Sharif S; Hashemzadeh S
Curr Probl Cancer; 2020 Feb; 44(1):100471. PubMed ID: 30904169
[TBL] [Abstract][Full Text] [Related]
23. Aberrantly methylated CDKN2A, MGMT, and MLH1 in colon polyps and in fecal DNA from patients with colorectal polyps.
Petko Z; Ghiassi M; Shuber A; Gorham J; Smalley W; Washington MK; Schultenover S; Gautam S; Markowitz SD; Grady WM
Clin Cancer Res; 2005 Feb; 11(3):1203-9. PubMed ID: 15709190
[TBL] [Abstract][Full Text] [Related]
24. Stool methylation-specific polymerase chain reaction assay for the detection of colorectal neoplasia in Korean patients.
Baek YH; Chang E; Kim YJ; Kim BK; Sohn JH; Park DI
Dis Colon Rectum; 2009 Aug; 52(8):1452-9; discussion 1459-63. PubMed ID: 19617759
[TBL] [Abstract][Full Text] [Related]
25. Genetic variants of methyl metabolizing enzymes and epigenetic regulators: associations with promoter CpG island hypermethylation in colorectal cancer.
de Vogel S; Wouters KA; Gottschalk RW; van Schooten FJ; de Goeij AF; de Bruïne AP; Goldbohm RA; van den Brandt PA; Weijenberg MP; van Engeland M
Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3086-96. PubMed ID: 19843671
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-20a in human faeces as a non-invasive biomarker for colorectal cancer.
Yau TO; Wu CW; Tang CM; Chen Y; Fang J; Dong Y; Liang Q; Ng SS; Chan FK; Sung JJ; Yu J
Oncotarget; 2016 Jan; 7(2):1559-68. PubMed ID: 26621842
[TBL] [Abstract][Full Text] [Related]
27. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
[TBL] [Abstract][Full Text] [Related]
28. Loss of ZG16 is associated with molecular and clinicopathological phenotypes of colorectal cancer.
Meng H; Li W; Boardman LA; Wang L
BMC Cancer; 2018 Apr; 18(1):433. PubMed ID: 29661177
[TBL] [Abstract][Full Text] [Related]
29. Use of DNA from human stools to detect aberrant CpG island methylation of genes implicated in colorectal cancer.
Belshaw NJ; Elliott GO; Williams EA; Bradburn DM; Mills SJ; Mathers JC; Johnson IT
Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1495-501. PubMed ID: 15342451
[TBL] [Abstract][Full Text] [Related]
30. Promoter methylation status of the MGMT, hMLH1, and CDKN2A/p16 genes in non-neoplastic mucosa of patients with and without colorectal adenomas.
Ye C; Shrubsole MJ; Cai Q; Ness R; Grady WM; Smalley W; Cai H; Washington K; Zheng W
Oncol Rep; 2006 Aug; 16(2):429-35. PubMed ID: 16820927
[TBL] [Abstract][Full Text] [Related]
31. Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis.
Xu XL; Yu J; Zhang HY; Sun MH; Gu J; Du X; Shi DR; Wang P; Yang ZH; Zhu JD
World J Gastroenterol; 2004 Dec; 10(23):3441-54. PubMed ID: 15526363
[TBL] [Abstract][Full Text] [Related]
32. Promoter hypermethylation of tumor-related genes in the progression of colorectal neoplasia.
Bai AH; Tong JH; To KF; Chan MW; Man EP; Lo KW; Lee JF; Sung JJ; Leung WK
Int J Cancer; 2004 Dec; 112(5):846-53. PubMed ID: 15386372
[TBL] [Abstract][Full Text] [Related]
33. Epigenetic remodeling in colorectal cancer results in coordinate gene suppression across an entire chromosome band.
Frigola J; Song J; Stirzaker C; Hinshelwood RA; Peinado MA; Clark SJ
Nat Genet; 2006 May; 38(5):540-9. PubMed ID: 16642018
[TBL] [Abstract][Full Text] [Related]
34. TMEM25 is a candidate biomarker methylated and down-regulated in colorectal cancer.
Hrašovec S; Hauptman N; Glavač D; Jelenc F; Ravnik-Glavač M
Dis Markers; 2013; 34(2):93-104. PubMed ID: 23324576
[TBL] [Abstract][Full Text] [Related]
35. DNA stool test for colorectal cancer: hypermethylation of the secreted frizzled-related protein-1 gene.
Zhang W; Bauer M; Croner RS; Pelz JO; Lodygin D; Hermeking H; Stürzl M; Hohenberger W; Matzel KE
Dis Colon Rectum; 2007 Oct; 50(10):1618-26; discussion 1626-7. PubMed ID: 17762966
[TBL] [Abstract][Full Text] [Related]
36. NGX6 gene mediated by promoter methylation as a potential molecular marker in colorectal cancer.
Liu M; Peng Y; Wang X; Guo Q; Shen S; Li G
BMC Cancer; 2010 Apr; 10():160. PubMed ID: 20423473
[TBL] [Abstract][Full Text] [Related]
37. Methylation and expression of the tumour suppressor, PRDM5, in colorectal cancer and polyp subgroups.
Bond CE; Bettington ML; Pearson SA; McKeone DM; Leggett BA; Whitehall VL
BMC Cancer; 2015 Jan; 15():20. PubMed ID: 25613750
[TBL] [Abstract][Full Text] [Related]
38. Methylation analysis of Gasdermin E shows great promise as a biomarker for colorectal cancer.
Ibrahim J; Op de Beeck K; Fransen E; Croes L; Beyens M; Suls A; Vanden Berghe W; Peeters M; Van Camp G
Cancer Med; 2019 May; 8(5):2133-2145. PubMed ID: 30993897
[TBL] [Abstract][Full Text] [Related]
39. Promoter Methylation Status of Two Novel Human Genes, UBE2Q1 and UBE2Q2, in Colorectal Cancer: a New Finding in Iranian Patients.
Mokarram P; Shakiba-Jam F; Kavousipour S; Sarabi MM; Seghatoleslam A
Asian Pac J Cancer Prev; 2015; 16(18):8247-52. PubMed ID: 26745068
[TBL] [Abstract][Full Text] [Related]
40. Identification of novel tumor markers in prostate, colon and breast cancer by unbiased methylation profiling.
Chung W; Kwabi-Addo B; Ittmann M; Jelinek J; Shen L; Yu Y; Issa JP
PLoS One; 2008 Apr; 3(4):e2079. PubMed ID: 18446232
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]